bacterial vaginosis
Conditions
Interventions
Treatment of bacterial vaginosis of spleen deficiency type during pregnancy with Wandai Tang:Wandai Decoction
Normal control group of vaginal microbiota during pregnancy:NA
Sponsors
Department of Obstetrics and Gynecology, Affiliated Hospital of Gansu University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 39 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria (1) Those who meet the diagnostic standards of TCM and Western medicine, and the syndrome differentiation of TCM is spleen deficiency; (2) Age between 20 and 40 years old, 32>= 37 weeks of gestation; (3) Patients who received treatment in the outpatient department of Associate Professor Zhao Fanqin in the Affiliated Hospital of Gansu University of Chinese Medicine and continued to take the soup; (4) Voluntarily agree to join this study, sign relevant informed consent, and be willing to bear the possible consequences and risks; (5) Those who can insist on completing all courses of treatment required by this study and receive treatment, observation and examination as required; (6) Willing to cooperate closely with interviewees; (7) Patients who did not use other hormone drugs and traditional Chinese medicine for treatment.
Exclusion criteria
Exclusion criteria: Exclusion criteria (1) Those who do not meet the diagnostic standards of Western medicine and TCM syndrome differentiation. (2) Patients with other genital tract inflammation, such as vulvovaginal candidiasis and trichomoniasis vaginitis; (3) Patients with autoimmune diseases and other diseases causing low immunity; (4) Repeated vaginal bleeding of placenta previa: (5) gestational diabetes mellitus (6) Having sex within one week; (7) Patients who have recently taken similar drugs for treatment, oral or vaginal external use of related or antagonistic drugs, and it is difficult to judge the efficacy of drugs or do not use drugs according to regulations, unable to judge the efficacy or incomplete data affect the efficacy or safety. (8) Allergic to multiple drugs; (9) Patients who fail to take medication on time and cannot judge the efficacy; (10) Allergic constitution or allergic to the study drug; (11) Unable to cooperate, such as complicated with neurological or mental diseases, or unwilling to cooperate;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbial 16rDNA sequencing technology;vaginal microecology;blood routine examination;interleukin-6;tumor necrosis factor;beta streptococcus; | — |
Countries
China
Contacts
Public ContactFenqin Zhao
Affiliated Hospital of Gansu University of Chinese Medicine
Outcome results
None listed